Details of the Drug Reposition

General Information of This Drug (ID: DMW3M7X)

Drug Name
TT11X   DMW3M7X
Drug Type
CAR-T cell therapy

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Hodgkin lymphoma DISX2OUL 2B30 Phase 2 [1]
------------------------------------------------------------------------------------
1 Preclinical Indication(s)
Indication Name Indication ID ICD-11 Status REF
Non-hodgkin lymphoma DISS2Y8A 2B33.5 Preclinical [1]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of Tessa Therapeutics